Repligen (RGEN) Tops Q4 EPS by 21c, Offers FY Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $167.24 -0.15%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.52, $0.21 better than the analyst estimate of $0.31. Revenue for the quarter came in at $108.6 million versus the consensus estimate of $93.88 million.
GUIDANCE:
Repligen sees FY2021 EPS of $1.86-$1.94, versus the consensus of $1.65. Repligen sees FY2021 revenue of $500-525 million, versus the consensus of $459.5 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
